Vaxart, a clinical-stage biotechnology company, announced a virtual stockholder fireside chat to discuss the reverse stock split proposal.
The senior management team will participate in the fireside chat on August 20, 2025.
Leading proxy advisory firms, ISS and Glass Lewis, support the reverse stock split proposal.
Support from Proxy Advisory Firms
ISS and Glass Lewis recommend stockholders support the reverse stock split proposal.
Stockholder Engagement
Fireside chat aims to answer stockholders' questions regarding the rationale for the reverse stock split.
Voting Deadline
Stockholders of record on July 29, 2025, are encouraged to vote by September 4, 2025.
- The fireside chat provides a direct channel for stockholders to engage with Vaxart's leadership.
- Support from proxy advisory firms enhances confidence in the reverse stock split proposal.
The virtual fireside chat presents a strategic opportunity for Vaxart to address stockholder concerns and seek support for the reverse stock split proposal.